We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
251
Incyte
INCY
$24.9B
$399K 0.01%
+3,476
New +$345K
PPG icon
252
PPG Industries
PPG
$23.4B
$384K 0.01%
3,172
+895
+39% +$99.7K
AER icon
253
AerCap
AER
$22.1B
$383K 0.01%
2,597
+93
+4% +$13.2K
ED icon
254
Consolidated Edison
ED
$39B
$383K 0.01%
3,408
+769
+29% +$83.6K
ENTG icon
255
Entegris
ENTG
$20B
$374K 0.01%
2,185
+228
+12% +$32.9K
CPRT icon
256
Copart
CPRT
$28.5B
$369K ﹤0.01%
13,126
+2,529
+24% +$81.7K
DOCS icon
257
Doximity
DOCS
$4.63B
$344K ﹤0.01%
+16,694
New +$369K
TW icon
258
Tradeweb Markets
TW
$21.4B
$341K ﹤0.01%
+3,703
New +$402K
IOT icon
259
Samsara
IOT
$24.3B
$326K ﹤0.01%
10,153
+1,747
+21% +$54.1K
LRN icon
260
Stride
LRN
$3.47B
$312K ﹤0.01%
3,612
+434
+14% +$39.9K
W icon
261
Wayfair
W
$14.4B
$308K ﹤0.01%
+3,223
New +$237K
FTAI icon
262
FTAI Aviation
FTAI
$18.9B
$304K ﹤0.01%
+1,155
New +$291K
GPN icon
263
Global Payments
GPN
$23.4B
$303K ﹤0.01%
+4,258
New +$293K
UMC icon
264
United Microelectronic
UMC
$56.8B
$289K ﹤0.01%
10,751
-10,396
-49% -$178K
DGX icon
265
Quest Diagnostics
DGX
$27.1B
$280K ﹤0.01%
1,316
+204
+18% +$40K
MDGL icon
266
Madrigal Pharmaceuticals
MDGL
$12.1B
$277K ﹤0.01%
+526
New +$269K
LMND icon
267
Lemonade
LMND
$3.84B
$277K ﹤0.01%
+4,454
New +$260K
AROC icon
268
Archrock
AROC
$5.43B
$272K ﹤0.01%
+6,721
New +$247K
QS icon
269
QuantumScape Corp
QS
$3.1B
$265K ﹤0.01%
34,893
+14,711
+73% +$110K
NTNX icon
270
Nutanix
NTNX
$18.6B
$263K ﹤0.01%
5,144
-913
-15% -$41.3K
PNFP icon
271
Pinnacle Financial Partners Inc
PNFP
$15B
$254K ﹤0.01%
+2,520
New +$242K
IDCC icon
272
InterDigital
IDCC
$8.41B
$250K ﹤0.01%
903
-4,939
-85% -$1.47M
EWBC icon
273
East-West Bancorp
EWBC
$17.6B
$250K ﹤0.01%
+1,936
New +$238K
CDW icon
274
CDW
CDW
$18.9B
$249K ﹤0.01%
+1,783
New +$224K
EOG icon
275
EOG Resources
EOG
$76.5B
$237K ﹤0.01%
+1,798
New +$245K
9 10
11
12 13

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.